Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Evaluation of the Safety and Efficacy of Direct Oral Anticoagulants Compared With Vitamin-K Antagonists in the Treatment of Left Ventricular Thrombosis. a Systematic Review and Meta-Analysis Publisher



Mehrpooya M1 ; Barakzehi MR2 ; Nikoobakhsh M3
Authors

Source: Heart and Lung Published:2024


Abstract

Background: Since the introduction of direct oral anticoagulants (DOACs) and their comparison with vitamin K antagonists (VKAs), conflicting results have been reported regarding the optimal treatment for left ventricular thrombosis (LVT). Objectives: In this meta-analysis, we intend to comprehensively evaluate the safety and efficacy of these treatments. Methods: All clinical trials and cohorts that compared the efficacy or safety of VKAs with DOACs in the treatment of LVTs were systematically searched until April 15, 2023. Results: The results of 32 studies with a pooled sample size of 4213 patients were extracted for meta-analysis. DOACs, especially rivaroxaban and apixaban, cause faster resolution, lower mortality, and fewer complications (SSE and bleeding events) than VKAs in the management of LVTs. Conclusion: Compared with VKAs, DOACs result in significantly faster (only rivaroxaban) and safer resolution of left ventricular thrombosis. © 2024
Other Related Docs
11. Prevalence of Preeclampsia and Eclampsia in Iran, Archives of Iranian Medicine (2016)